Shares of Renergen (ASX:RLT) remain unchanged in recent Monday trade after the company said in a late Friday Australian bourse filing that all remaining conditions for the acquisition by ASP Isotopes (ASPI) have been fulfilled or waived, preventing the activation of a standby offer.

The scheme's implementation depends on fulfilling or waiving outstanding offer conditions by Sept. 30, unless extended, the filing said.

An independent expert has valued each share appreciation right (SAR) at 0.09 South African rand, while ASPI's cash offer of 0.08 South African rand per SAR is deemed reasonable, but slightly unfavorable to participants, the filing added.

After receiving approval from the takeover regulation panel, the company and ASPI shared detailed information with SAR holders, finalized settlements, and received an exemption to skip making a comparable offer to SAR holders, per the filing.